Lipoxygenases as therapeutic targets in the acute and subacute phases of glomerular immune injury.
Badr
K F
KF
Renal Division, Emory University, Atlanta, Ga., USA.
D000818:Animals; D005921:Glomerulonephritis / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D006893:Hydroxyeicosatetraenoic Acids / Q000627:therapeutic use*; D007678:Kidney Glomerulus / Q000276:immunology*; D015289:Leukotrienes / Q000502:physiology; D044045:Lipoxins; D008084:Lipoxygenase / Q000502:physiology*; D008264:Macrophages / Q000502:physiology; D009504:Neutrophils / Q000502:physiology
D006893:Hydroxyeicosatetraenoic Acids; D015289:Leukotrienes; D044045:Lipoxins; C040527:lipoxin A4; C025984:15-hydroxy-5,8,11,13-eicosatetraenoic acid; D008084:Lipoxygenase